Stay updated on Perjeta & Herceptin in HER2+ Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Perjeta & Herceptin in HER2+ Breast Cancer Clinical Trial page.

Latest updates to the Perjeta & Herceptin in HER2+ Breast Cancer Clinical Trial page
- Check5 days agoChange DetectedA new identifier '2014 ( U.S. NIH Grant/Contract )' was added to the study's external identifiers. It serves as supplementary reference information in the trial record.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedRevision badge at the bottom of the study page updated from v3.6.4 to v3.6.5, indicating a small maintenance update to the page.SummaryDifference0.0%

- Check34 days agoChange DetectedThe page's revision tag was updated from v3.6.3 to v3.6.4, indicating a minor update to the page's metadata. There is no shown change to core study content or user-facing information.SummaryDifference0.0%

- Check62 days agoChange DetectedThe page now shows Revision: v3.6.3, replacing the previous Revision: v3.6.0.SummaryDifference0.0%

- Check76 days agoChange DetectedThe page now shows that the study is no longer recruiting participants, signaling closed enrollment. It also adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the revision to v3.6.0.SummaryDifference0.2%

- Check84 days agoChange DetectedFooter revision tag updated from v3.5.4 to v3.5.5, indicating a small page version update. No other visible content changes are indicated.SummaryDifference0.0%

Stay in the know with updates to Perjeta & Herceptin in HER2+ Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Perjeta & Herceptin in HER2+ Breast Cancer Clinical Trial page.